Si, J., Hao, Y., Wei, J., Xiang, J., Xu, C., Shen, Q., & Song, Z. (2023). Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations. BMC Pulmonary Medicine, 23(1), 1. https://doi.org/10.1186/s12890-023-02466-9
Chicago-referens (17:e uppl.)Si, Jinfei, Yue Hao, Jingwen Wei, Jing Xiang, Chunwei Xu, Qiuping Shen, och Zhengbo Song. "Clinical Outcomes of Immune Checkpoint Inhibitors to Treat Non-small Cell Lung Cancer Patients Harboring Epidermal Growth Factor Receptor Mutations." BMC Pulmonary Medicine 23, no. 1 (2023): 1. https://doi.org/10.1186/s12890-023-02466-9.
MLA-referens (9:e uppl.)Si, Jinfei, et al. "Clinical Outcomes of Immune Checkpoint Inhibitors to Treat Non-small Cell Lung Cancer Patients Harboring Epidermal Growth Factor Receptor Mutations." BMC Pulmonary Medicine, vol. 23, no. 1, 2023, p. 1, https://doi.org/10.1186/s12890-023-02466-9.
